NCT05129774Not yet recruiting
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
Concurrent Chemoradiotherapy Sequenced Radical Surgery for Para-aortic Lymph Node Metastasis of Left-sided Colon and Rectal Cancer
Source: ClinicalTrials.gov · Last updated 22 Nov 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In left-sided colon and rectal cancer, the occurrence of synchronous para-aortic lymph node metastasis is rare, with the incidence of being approximate 1-2%. Currently, there has been no standard treatment strategy for this situation. The present trial is designed to evaluate the safety and efficacy of para-aortic lymph node dissection for left-sided colon and rectal cancer with synchronous para-aortic lymph node metastasis
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 28 Oct 2021
- Start date
- Jan 2022
- Primary completion date
- Jan 2024
- Lead sponsor
- Qilu Hospital of Shandong University
- Diseases
- Colorectal cancer
- NCT number
- NCT05129774
What you commit to
- Study type: Interventional
- Planned participants: 40
- From Jan 2022 to the primary completion date, Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- emergency surgery
Other illness
- history of other malignant tumor
- coupled with severe systematic diseases (recent myocardial infarction, cardiomyopathy, or acute pulmonary infection)
Other
- local invasion or distant metastasis other than para-aoritc lymph nodes
Who the study is looking for
- age at enrollment is ≥ 18 and ≤ 75 years
- ECOG PS 0-1
- histologically confirmed left-sided colon and rectal carcinoma
- synchronous para-aortic lymph node metastases confirmed by PET-CT, and located below the level of renal veins and above the bifurcation of iliac artery
- patients potential to receive surgery and achieve no evidence of disease (NED)
- able to tolerate surgery
- providing written informed consent
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Qilu Hospital of Shandong University Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.